Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortCholesterol injection given twice a year.Injection that cuts LDL cholesterol by about 60%.
Body systemHeart & CholesterolHeart & Cholesterol
Drug classPCSK9 inhibitorsPCSK9 inhibitors
SupplyPrescription onlyPrescription only
Main usesHigh LDL cholesterol despite statins, Familial hypercholesterolaemiaHigh LDL cholesterol despite statins, Familial hypercholesterolaemia, Established cardiovascular disease
How it worksSwitches off the liver's instructions to make PCSK9.Stops a protein from destroying the liver's cholesterol 'catchers'.
Starts working——
Half-life—11–17 days
Typical adult dose284 mg under the skin at day 0, at 3 months, then every 6 months.140 mg every 2 weeks or 420 mg once a month under the skin.
FormsPre-filled syringePre-filled pen injection
Common side effectsInjection-site reactions, Joint painInjection-site reactions, Cold-like symptoms, Back pain
Serious side effectsNone common in trialsAllergic reactions (rare)
Don't take if——
Alcohol——
PregnancyUse with cautionNot recommended; no data.Use with cautionAntibodies cross the placenta later in pregnancy; limited data.
Breastfeeding——
In use since20202015
Brand namesUnited States: LeqvioUnited Kingdom: LeqvioIndia: SybravaUnited States: RepathaUnited Kingdom: RepathaIndia: Repatha
Legal status——
ATC codeC10AX16C10AX13

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker